Reference health

Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications

https://doi.org/10.1039/d1cs00918d
CiteStamped reference-health badge
61/61 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 61 checked references that resolve
resolves10.1002/anie.202101644
25 Years of Reticular Chemistry
resolves10.1002/anie.202106259
The Current Status of MOF and COF Applications
resolves10.1002/adfm.201909062
The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, and COF Materials
resolves10.1351/pac200476051033
Glossary of terms used in toxicokinetics (IUPAC Recommendations 2003)
resolves10.1039/C3CS60338E
Perturbation of physiological systems by nanoparticles
resolves10.1039/C6CS00636A
Cellular uptake of nanoparticles: journey inside the cell
resolves10.1007/978-1-4939-8916-4_7
Measurement of Nanoparticle-Induced Mitochondrial Membrane Potential Alterations
resolves10.1186/s11671-020-03344-7
Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field
resolves10.1186/s40169-018-0212-7
Cell toxicity mechanism and biomarker
resolves10.3390/cells8101209
The Hemocompatibility of Nanoparticles: A Review of Cell–Nanoparticle Interactions and Hemostasis
resolves10.1186/s12989-019-0292-6
Silver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population
resolves10.1016/j.chempr.2020.11.021
Synergistic Combination of Calcium and Citrate in Mesoporous Nanoparticles Targets Pleural Tumors
resolves10.1038/nnano.2012.207
Biomolecular coronas provide the biological identity of nanosized materials
resolves10.1021/acsnano.8b06287
Coordinative Binding of Polymers to Metal–Organic Framework Nanoparticles for Control of Interactions at the Biointerface
resolves10.1002/adhm.201400755
Heparin‐Engineered Mesoporous Iron Metal‐Organic Framework Nanoparticles: Toward Stealth Drug Nanocarriers
resolves10.1016/j.ijbiomac.2019.08.183
Protein corona of metal-organic framework nanoparticals: Study on the adsorption behavior of protein and cell interaction
resolves10.1039/C6TB01652A
Biocompatible polymer–metal–organic framework composite patches for cutaneous administration of cosmetic molecules
resolves10.1021/jacs.8b04435
Metal–Organic Frameworks as Efficient Oral Detoxifying Agents
resolves10.3390/nano10122296
Combined Cutaneous Therapy Using Biocompatible Metal-Organic Frameworks
resolves10.1371/journal.pone.0010202
Limitations of MTT and MTS-Based Assays for Measurement of Antiproliferative Activity of Green Tea Polyphenols
resolves10.1021/ja803383k
Nanoscale Coordination Polymers for Platinum-Based Anticancer Drug Delivery
resolves10.1038/nmat2608
Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging
resolves10.1021/cr200256v
Metal–Organic Frameworks in Biomedicine
resolves10.1039/C3TB20832J
Cytotoxicity of nanoscaled metal–organic frameworks
resolves10.1039/C5TB01223F
In vitro biocompatibility of mesoporous metal (III; Fe, Al, Cr) trimesate MOF nanocarriers
resolves10.1039/C5CC00745C
A biocompatible porous Mg-gallate metal–organic framework as an antioxidant carrier
resolves10.1039/C5CC05237H
Amorphous metal–organic frameworks for drug delivery
resolves10.1002/adhm.201600818
Validating Metal‐Organic Framework Nanoparticles for Their Nanosafety in Diverse Biomedical Applications
resolves10.1021/acsami.8b11652
Surface-Functionalization of Zr-Fumarate MOF for Selective Cytotoxicity and Immune System Compatibility in Nanoscale Drug Delivery
resolves10.1039/C8TB01899E
Metal–organic framework nanoparticles for arsenic trioxide drug delivery
resolves10.1002/ange.201913135
Tuning Cellular Biological Functions Through the Controlled Release of NO from a Porous Ti‐MOF
resolves10.1021/acsami.0c21508
Cracking the Chloroquine Conundrum: The Application of Defective UiO-66 Metal–Organic Framework Materials to Prevent the Onset of Heart Defects—In Vivo and In Vitro
resolves10.1002/chem.201405380
Synthesis, Culture Medium Stability, and In Vitro and In Vivo Zebrafish Embryo Toxicity of Metal–Organic Framework Nanoparticles
resolves10.3389/fbioe.2021.584115
A Simple in vivo Assay Using Amphipods for the Evaluation of Potential Biocompatible Metal-Organic Frameworks
resolves10.1021/acsanm.8b00140
Toxicity and Antimicrobial Properties of ZnO@ZIF-8 Embedded Silicone against Planktonic and Biofilm Catheter-Associated Pathogens
resolves10.1002/chem.201402244
Mechanical Downsizing of a Gadolinium(III)‐based Metal–Organic Framework for Anticancer Drug Delivery
resolves10.1021/acsabm.0c00107
Luminescent Marker for GSR: Evaluation of the Acute Oral and Inhalation Toxicity of the MOF [Eu(DPA)(HDPA)]
resolves10.1016/j.cej.2020.124446
A multifunctional MOF-based nanohybrid as injectable implant platform for drug synergistic oral cancer therapy
resolves10.1002/anie.201707346
A Smart Metal–Organic Framework Nanomaterial for Lung Targeting
resolves10.1039/C9CE00757A
Degradation of ZIF-8 in phosphate buffered saline media
resolves10.1021/la5012555
Understanding the Colloidal Stability of the Mesoporous MIL-100(Fe) Nanoparticles in Physiological Media
resolves10.1038/srep07925
A “green” strategy to construct non-covalent, stable and bioactive coatings on porous MOF nanoparticles
resolves10.1002/smll.201801900
GraftFast Surface Engineering to Improve MOF Nanoparticles Furtiveness
resolves10.1016/j.chempr.2017.02.005
Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Delivery
resolves10.1021/acs.chemmater.6b00180
Imparting Functionality to MOF Nanoparticles by External Surface Selective Covalent Attachment of Polymers
resolves10.1021/ja00905a001
<b>Hard and Soft Acids and Bases</b>
resolves10.1039/c2dt30357d
Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle
resolves10.1016/j.micromeso.2015.01.032
Stability of UiO-66 under acidic treatment: Opportunities and limitations for post-synthetic modifications
resolves10.1002/cnma.202000221
Zn‐MOF‐74 as pH‐Responsive Drug‐Delivery System of Arsenic Trioxide
resolves10.1021/jacs.8b02089
Acid-Resistant Mesoporous Metal–Organic Framework toward Oral Insulin Delivery: Protein Encapsulation, Protection, and Release
resolves10.3390/nano11030722
Degradation Mechanism of Porous Metal-Organic Frameworks by In Situ Atomic Force Microscopy
resolves10.1021/jm4017202
A “Ship in a Bottle” Strategy To Load a Hydrophilic Anticancer Drug in Porous Metal Organic Framework Nanoparticles: Efficient Encapsulation, Matrix Stabilization, and Photodelivery
resolves10.1039/c3cc41987h
A rare example of a porous Ca-MOF for the controlled release of biologically active NO
resolves10.1021/jacs.0c07525
A Robust and Biocompatible Bismuth Ellagate MOF Synthesized Under Green Ambient Conditions
resolves10.1039/c3sc22116d
In depth analysis of the in vivo toxicity of nanoparticles of porous iron(iii) metal–organic frameworks
resolves10.3389/fbioe.2020.576348
Surface Engineered Metal-Organic Frameworks (MOFs) Based Novel Hybrid Systems for Effective Wound Healing: A Review of Recent Developments
resolves10.1016/j.jhazmat.2021.125056
Metal-organic frameworks functionalized smart textiles for adsorptive removal of hazardous aromatic pollutants from ambient air
resolves10.1021/acsami.0c07356
Metal–Organic Framework Microsphere Formulation for Pulmonary Administration
resolves10.1680/gmat.13.00001
‘Green’ fluorine-free mesoporous iron(III) trimesate nanoparticles for drug delivery
resolves10.1002/adhm.201200454
Towards an Improved anti‐HIV Activity of NRTI via Metal–Organic Frameworks Nanoparticles
resolves10.1038/s41565-018-0246-4
Minimum information reporting in bio–nano experimental literature
The 5 references without a DOI — listed, not checked
no DOI — not checkedD1CS00918D/cit5/1
no DOI — not checkedD1CS00918D/cit14/1
no DOI — not checkedD1CS00918D/cit40/1
no DOI — not checkedD1CS00918D/cit48/1
no DOI — not checkedRegulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, 2006
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1039/d1cs00918d"><img src="https://citestamp.com/citestamped/10.1039/d1cs00918d/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1039/d1cs00918d/badge.svg)](https://citestamp.com/citestamped/10.1039/d1cs00918d)